Unimax Lifescience Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 22-05-2024
- Paid Up Capital ₹ 0.10 M
as on 22-05-2024
- Company Age 13 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.00 M
as on 22-05-2024
- Revenue 134.59%
(FY 2022)
- Profit 61.64%
(FY 2022)
- Ebitda -2047.34%
(FY 2022)
- Net Worth -10.96%
(FY 2022)
- Total Assets -28.19%
(FY 2022)
About Unimax Lifescience
The Company is engaged in the Service Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.00 M.
Alpaben Shah and Umang Shah serve as directors at the Company.
- CIN/LLPIN
U24239GJ2011PTC064694
- Company No.
064694
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Mar 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Unimax Lifescience?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Alpaben Shah  | Director | 31-Mar-2011 | Current |
| Umang Shah | Director | 31-Mar-2011 | Current |
Financial Performance of Unimax Lifescience.
Unimax Lifescience Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 134.59% increase. The company also saw a substantial improvement in profitability, with a 61.64% increase in profit. The company's net worth observed a substantial decline by a decrease of 10.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Unimax Lifescience?
In 2017, Unimax Lifescience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Panjab National Bank Sanjivani Road Branch Creation Date: 07 Oct 2014 | ₹2.00 M | Open |
How Many Employees Work at Unimax Lifescience?
Unlock and access historical data on people associated with Unimax Lifescience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Unimax Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unimax Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
